Verition Fund Management
MREO

Verition Fund Management’s Mereo BioPharma MREO Stock Holding History

Verition Fund Management’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-237,777
Closed -$832K – 3569
2024
Q4 		$832K Buy
237,777
+127,773
+116% +$502K ﹤0.01% 2171
2024
Q3 		$452K Sell
110,004
-116,490
-51% -$482K ﹤0.01% 2380
2024
Q2 		$815K Sell
226,494
-258,942
-53% -$839K ﹤0.01% 1801
2024
Q1 		$1.6M Buy
+485,436
New +$1.64M 0.01% 1343
2020
Q3 		– Sell
-395,290
Closed -$1.21M – 1265
2020
Q2 		$1.21M Buy
+395,290
New +$697K 0.04% 360

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Verition Fund Management's MREO Position: Q1 2025 in Review

Verition Fund Management sold out of Mereo BioPharma (MREO) in Q1 2025, closing a stake of 237,777 shares — an estimated $832K sold.

Verition Fund Management first reported a position in MREO in Q2 2020 and held it in 5 quarters. The position peaked at $1.6M in Q1 2024. 90 funds tracked by Wall St. Rank hold MREO as of Q1 2025.

  • Verition Fund Management reported no remaining Mereo BioPharma position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 237,777 Mereo BioPharma shares in Q1 2025, an estimated $832K.
  • Verition Fund Management first reported a position in Mereo BioPharma in Q2 2020 and held it in 5 quarters.
  • Verition Fund Management's Mereo BioPharma position peaked at $1.6M in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.